{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:08:58Z","timestamp":1787933338045,"version":"build-2784847793"},"reference-count":35,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2013,7,13]]},"DOI":"10.4161\/hv.24502","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T15:58:00Z","timestamp":1371139080000},"page":"1454-1459","source":"Crossref","is-referenced-by-count":17,"title":["Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV)"],"prefix":"10.1080","volume":"9","author":[{"given":"Claudius","family":"Malerczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshang B.","family":"Vakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,4,9]]},"reference":[{"key":"R1","first-page":"360","volume":"83","author":"Knobel DL","year":"2005","journal-title":"Bull World Health Organ"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.10.007"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.93534"},{"key":"R5","unstructured":"Puanghat A. Human rabies in Thailand. In: Dodet B, Meslin F-X, Heseltine E, editors. Rabies Control in Asia. Paris: John Libbey Eurotext, 2001:252-3."},{"key":"R6","unstructured":"Wimalaratne O. Rabies in humans and animals in Sri Lanka. In: Dodet B, Meslin F-X, Heseltine E, eds. Rabies Control in Asia.Paris: John Libbey Eurotext, 2001:248-51."},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.4.644"},{"key":"R8","first-page":"309","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.81786"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.08.054"},{"key":"R11","first-page":"27","volume":"40","author":"Ichhpujani RL","year":"2008","journal-title":"J Commun Dis"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199706000-00016"},{"key":"R13","first-page":"693","volume":"78","author":"Briggs DJ","year":"2000","journal-title":"Bull World Health Organ"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.027"},{"key":"R15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4269\/ajtmh.1985.34.633","volume":"34","author":"Bernard KW","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"R16","first-page":"81","volume":"86","author":"Rosa FW","year":"1983","journal-title":"J Trop Med Hyg"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91014-6"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1086\/520143"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10085-4"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90309-7"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199811000-00007"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmm100"},{"key":"R23","unstructured":"Chanthavanich P, Sabchareon A, Singhasivanon V, Pojjaroen-Anant C, Chongsuphajaisiddhi T, Kittikoon P. Dose-related antibody responses to purified Vero cell rabies vaccine in healthy Thai children. In: Dodet B, Meslin FX (editors). Rabies control in Asia. Paris: Elsevier; Paris; 1997. 97\u2013100."},{"key":"R24","first-page":"99","volume":"7","author":"Lumbiganon P","year":"1989","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181906351"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.02.044"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/403201"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.5.5987"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/40.6.345"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.08.036"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004708"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1086\/313610"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1080\/003655401750174183"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.03.059"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.117"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001891"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.24502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T10:11:58Z","timestamp":1563185518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.24502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,9]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,4,12]]},"published-print":{"date-parts":[[2013,7,13]]}},"alternative-id":["10.4161\/hv.24502"],"URL":"https:\/\/doi.org\/10.4161\/hv.24502","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,9]]}}}